Analystreport

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com